60 Degrees Pharmaceuticals (SXTP) Earnings Date & Reports

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

SXTP is expected to report earnings to fall 97.69% to -10 cents per share on May 14

60 Degrees Pharmaceuticals SXTP Stock Earnings Reports

Q1'25

Est.

$-0.11

Q4'24

Missed

by $4.59

Q3'24

Missed

by $0.71

Q2'24

Missed

by $4.03

Q1'24

Beat

by $0.21

The last earnings report on February 26 showed earnings per share of -476 cents, missing the estimate of -18 cents. With 73.43K shares outstanding, the current market capitalization sits at 2.67M.

View a ticker or compare two or three

Compare

SXTP